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  Mesenchymal stem cells (MSCs) secrete a variety of neu-
roregulatory  molecules,  such  as  nerve  growth  factor, 
brain-derived  neurotrophic  factor,  and  glial  cell-derived 
neurotrophic  factor,  which  upregulate  tyrosine  hydrox-
ylase (TH) gene expression in PC12 cells. Enhancing TH 
gene  expression  is  a  critical  step  for  treatment  of 
Parkinson's disease (PD). The objective of this study was 
to assess the effects of co-culturing PC12 cells with MSCs 
from feline bone marrow on TH protein expression. We 
divided  the  study  into  three  groups:  an  MSC  group,  a 
PC12  cell  group,  and  the  combined  MSC + PC12  cell 
group  (the  co-culture  group).  All  cells  were  cultured  in 
DMEM-HG medium supplemented with 10% fetal bovine 
serum for three days. Thereafter, the cells were examined 
using western blot analysis and immunocytochemistry. In 
western blots, the co-culture group demonstrated a stron-
ger signal at 60 kDa than the PC12 cell group (p ＜ 0.001). 
TH was not expressed in the MSC group, either in western 
blot or immunocytochemistry. Thus, the MSCs of feline 
bone  marrow  can  up-regulate  TH  expression  in  PC12 
cells.  This  implies  a  new  role  for  MSCs  in  the  neuro-
degenerative disease process.
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Introduction 
  Parkinson's disease (PD) is characterized by a loss of dop-
amine in the striatum resulting from the progressive degen-
eration of dopaminergic neurons within the substantia ni-
gra [20]. Tyrosine hydroxylase (TH) is the rate-limiting en-
zyme in the synthesis of catecholamine, and is widely used 
as a marker of dopaminergic cells [23]. Tang et al. [32] 
have shown that dopaminergic differentiation of stria-
tum-derived precursor cells following transplantation re-
quires TH induction. Furthermore, Lu et al. [16] observed 
significant functional recovery in rats model of PD receiv-
ing TH-engineered mesenchymal stem cells transplanted 
into the striatum. Moreover, Peschanski et al. [25] have 
demonstrated bilateral motor improvement in two patients 
with PD after grafting of fetal mesencephalic tissue. 
Therefore, enhancing TH gene expression or protein pro-
duction is a critical step for treatment of PD. 
  The PC12 cell line is a neural crest-derived adrenal chro-
maffin cell line obtained from a rat pheochromocytoma. 
PC12 cells serve as a useful model system for studying the 
molecular mechanisms responsible for sympathetic neuro-
nal differentiation induced by nerve growth factor (NGF) 
because they can synthesize and store the catecholamine 
neurotransmitters dopamine and norepinephrine [8]. 
Mesenchymal stem cells (MSCs) derived from bone mar-
row can differentiate into osteoblasts, chondrocytes, adi-
pocytes [26], and neural cells [15,24]. In addition, MSCs 
express neuroregulatory molecules, such as NGF, brain- 
derived neurotrophic factors (BDNF), and glial cell-de-
rived neurotrophic factors (GDNF) [5,6,14,17,18]. NGF 
can upregulate TH gene expression in PC12 cells [7,13]. 
Others have reported that induction of TH gene expression 
can be achieved by co-treatment fetal cerebral cortex with 
dopamine and BDNF [37,38]. Therefore, novel methods of 
inducing TH expression via treatment with growth factors, 
either directly or through cell co-cultures, has significant 
potential.
  Co-cultures of two different cell types provide insight in-
to mechanisms of cell-cell interactions. Direct-contact 
co-cultures can promote more mature differentiation of 
neural stem cells [30], which also involves the ex-
tracellular matrix or soluble factors secreted by supporting 
cells [1,30,31]. Moreover, direct contact cultures better 
mimic intracerebral grafting in terms of the cell-cell 
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  The cat is the preferred model for studying human neuro-
degerative disorders [3,19,27,36]. It provides a number of 
important advantages for biomedical research, particularly 
stem cell transplantation in fetal and postnatal animals. 
The purpose of this study was to explore whether MSCs 
derived from feline bone marrow could enhance the ex-
pression of TH in PC12 cells by direct contact co-cultures.
Materials and Methods
Isolation and culture of feline MSCs
  The protocol used in this study was approved by the 
Gyeongsang National University Animal Use Committee. 
Feline bone marrow was harvested by bone marrow aspira-
tion from a greater trochanter of the femur. Mononuclear 
cells were isolated from the collected samples by the Ficoll 
400 (Sigma, USA) density gradient method. The cells were 
then rinsed twice with PBS, and grown in Dulbeco's 
Modified Eagle high glucose medium (DMEM, 4.5 g/l glu-
cose; Gibco-BRL, USA) with 10% fetal bovine serum 
(FBS; Gibco-BRL, USA) and penicillin/streptomycin (50 
IU/ml / 50 µg/ml; Sigma, USA). After 5 days, the resulting 
monolayer of cells, hereafter named bone marrow-derived 
MSCs, was trypsinized and aliquots were frozen and stored 
or cultivated further. 
Co-culture of PC12 cells and MSCs
  MSCs were from passage 4. The study was divided into 
three experimental groups: a MSC group, a PC12 cell 
group, and the combined MSC + PC12 cell group. The 
cells were seeded at 1.5 × 10
5 cells of each cell type (3 × 10
5 
total in the combined group) onto 60 mm dishes and grown 
in DMEM supplemented with 10% FBS and penicillin/ 
streptomycin (50 IU/ml / 50 µg/ml). Cells were incubated 
at 37 °C in a humidified atmosphere of 5% CO2 for 3 days.
Flow cytometric determination of cell-surface anti-
gen profile
  Ten microliters of CD9 (Serotec, USA), CD18, CD44, 
and CD45-like (VMRD, USA) cat-specific antibodies 
were added to the bottom of tubes, followed by 100 µl of 6 
× 10
6 cells/ml single cell suspensions of cultured MSCs in 
the 4th passage. The mixture was incubated for 30 min at 
4°C in the dark and washed. Five microliters fluo-
rescent-tagged secondary antibodies were then added to 
the resuspended cells for 30 min at 4°C in the dark. Positive 
cells were then detected on flow cytometers. 
Immunocytochemistry of MSCs and TH expression 
in PC12 cells 
  To identify MSCs from feline derived bone marrow, the 
primary chicken anti-vimentin antibody (1 : 5,000, poly-
clonal; Chemicon, USA) was employed; the secondary an-
tibody was a FITC-conjugated antibody against chicken 
IgG (1 : 320; Sigma, USA). To identify TH-positive differ-
entiation of feline MSCs in co-cultures experiment, MSCs 
were prelabeled using Dil-Ac-LDL (1 : 20; Biomedical 
Technologies, USA) and then co-cultured with PC12 for 
three days. Anti-TH (1 : 500, polyclonal; Chemicon, USA) 
was the primary antibody used to identify TH in all groups; 
a FITC-labeled antibody against rabbit IgG (1 : 80; Sigma, 
USA) was used as the secondary antibody. The cells were 
cultured in a four-well chamber slide and fixed with 4% 
paraformaldehyde for 10 min. Following fixation, the cells 
were treated with 0.3% Triton X-100 containing 10% nor-
mal goat serum for 30 min. Cells were then incubated with 
the primary antibody at room temperature for 2 h, followed 
by incubation with the FITC-conjugated secondary anti-
body at 37°C for 30 min. To prevent non-specific staining, 
secondary antibodies were used at the same concentrations 
as the primary antibodies. The slides were examined with 
an microscope (Olympus, Japan) equipped with fluo-
rescent illumination.
Western blots of TH protein
  Western blot analysis was performed to determine wheth-
er the presence of MSCs affected TH protein expression in 
PC12 cells. The cells were lysed using a SDS-sample 
buffer. After ultracentrifugation (12,000 rpm/4°C/10 min), 
the supernatant was collected. Fifteen μg of protein was 
separated by SDS-PAGE and transferred to a PVDF mem-
brane (Bio-Rad, USA). Immunoreactions were performed 
with antibodies against TH (1 : 500, polyclonal; Chemicon, 
USA) and GAPDH (1 : 300, monoclonal; Chemicon, 
USA). The membrane was washed and incubated with 
horseradish peroxidase conjugated anti-rabbit IgG (1 :
1,000; Santa Cruz Biotechnology, USA) or anti-mouse 
IgG (1 : 5,000; Chemicon, USA). Antigen protein was vi-
sualized using chemiluminescence with an ECL-detecting 
reagent (Amersham Pharmacia Biotech, USA) according 
to the protocol of the manufacturer. 
Statistical analysis
  Experiments were repeated three times. The band from 
the western blot was scanned and analyzed by densi-
tometry using the Sigma Gel System (SPSS, USA). 
Density values are expressed as the mean ± SD. Statistical 
analysis was performed using one-way ANOVA analysis 
followed by a posthoc LSD test. The acceptance level for 
statistical significance was p＜0.05.
Results
Establishment of primary culture
  The feline bone marrow-derived mononuclear fraction 
was isolated and then cultured. Attached cells were ob-
served at 10-14 days after the initial plating. These cells 
comprised a morphologically heterogeneous population of Tyrosine hydroxylase expression in PC12 cells    379
Fig. 2. Flow cytometric determination of cell-surface antigen 
profiles for feline MSC. Feline bone marrow MSCs were stained
with feline specific antibodies to a variety of cell-surface 
antigens. The percentage of cells positive for each antibody is 
listed in the corresponding histogram. An isotype control is used 
to identify background fluorescence. MSC from 3 separate cats 
were tested with similar results. Representative results from 1 cat
are shown.
Fig. 1. Identification of isolated bone marrow-derived MSCs. 
(A) Phase contrast image of heterogeneous MSCs after passage 
1. (B) Phase contrast image of fibroblast-like, homogeneous 
MSCs after passage 4. (C) Immunostaining of vimentin antigen, 
a marker expressed by BMCs. Scale bar = 200 µm, A and B; 50 
µm, C.
cells that included spindle-shaped cells, large flat cells, and 
small round cells (Fig. 1A). 
Morphology and characterization of MSCs culture
  Upon a fourth passage of adherent cells, a homogeneous 
population of fibroblast-like cells progressively arose from 
the feline bone marrow-derived mononuclear cells (Fig. 
1B). Identification of mesenchymal stem cells was per-
formed with a primary anti-vimentin antibody (Fig. 1C).
Cell-surface antigen profile
  The feline MSC-surface antigen profile was ascertained 
by staining with feline-specific monoclonal antibodies fol-
lowed by flow cytometry (Fig. 2). Feline MSCs were 
strongly positive for CD9 and CD44, but negative for 
CD18 and CD45. They demonstrated typical character-
istics of mesenchymal cells, including the capacity to 
transform into osteocytes and adipocytes.
Morphology in co-culture of PC12 cells and MSCs
  In the MSCs alone, the cells showed an elongated fibro-
blast shape (Fig. 3A). In the PC12 cells alone, the cells 
showed modest growth and tended to grow in small clus-
ters (Fig. 3B). In the co-cultured group, both cells appeared 
robust. Although the PC12 cells did not change morphol-
ogy significantly, the MSCs possessed long, thin, complex 
processes (Fig. 3C). 
Western blot analysis of TH expression in PC12 and 
MSC co-cultures
  Representative immunoblot bands for TH proteins are 
shown in Fig. 4. TH protein demonstrated a stronger signal 
at 60 kDa in the co-culture group than the PC12 cell group 
(p＜0.001). In contrast, TH wasn't expressed in the MSC 
alone group. 
Immunocytochemistry  of  TH  expression  in  PC12 
and MSC co-cultures
  MSCs (red) did not show immunostaining of TH protein 
(green) (Figs. 5A-C), indicating that the MSCs had not dif-
ferentiated into TH positive cells under our experimental 
conditions.
Discussion
  Here, we show that MSCs derived from feline bone mar-
row can enhance TH protein expression in PC12 cells. 
There are several possibilities for what mediates this 380    Guang-Zhen Jin et al.
Fig. 3. Phase contrast image of PC12 cells and MSCs. (A) MSCs
cultured alone for 3 days. The cells exhibited an elongated spin-
dle shape resembling fibroblasts. (B) PC12 cells cultured alone 
for 3 days. The cells tended to grow in small clusters. (C) PC12 
cells were co-cultured with MSCs for 3 days. The PC12 cells 
were not significantly changed, but the MSCs possessed a longer,
more complex processes (white arrowheads). Scale bar = 200 µm.
Fig. 4. Representative Western blot analysis of TH proteins. (A) Immunoblots of TH and GAPDH protein expression. M, molecular 
marker, Lane 1, MSC group; Lane 2, PC12 group; Lane 3, MSC + PC12 group. (B) Ratio of TH to GAPDH density values in A. TH
expression was significantly increased in the MSC + PC12 group. **p＜0.001 vs. PC12 group. 
Fig. 5. Fluorescence micrographs of co-cultures of PC12 cells 
(green) and MSCs (red) for three days. (A) MSCs prelabeled with
Dil-Ac-LDL (red). (B) PC12 cells stained with a rabbit anti-TH 
antibody (green). (C) Merged image of A and B. MSCs were not
TH positive. Scale bar = 100 µm.
induction. First, PC12 cells can synthesize and release dop-
amine [8], and MSCs can secrete NGF and BDNF [5]. 
NGF can up-regulate TH mRNA expression in PC12 cells 
[13], and TH gene expression can be induced in human and 
murine fetal cerebral cortex by co-treatment with dop-
amine and BDNF [37,38]. Therefore, the NGF and BDNF 
produced by MSCs and the dopamine from PC12 cells 
could stimulate TH induction [13,37,38]. 
  Second, PC12 cells originated from adrenal chromaffin 
cell-derived tumors [8]. Adrenal medullary chromaffin 
cells produce FGF-2, TGF-β, GDNF, etc [11,35]. Adult rat 
bone marrow stromal cells express genes which are asso-
ciated with dopaminergic neurons [10], and MSCs can dif-
ferentiate into dopaminergic neurons both in vitro and in 
vivo [12,33,34]. Here, MSCs did not express TH in western 
blots or immunostaining, perhaps due to immaturity of the 
cells at the time of the immunocytochemical study. 
  Third, studies in both chromaffin and PC12 cells reveal 
that TH gene expression is dependent on cell density 
[2,8,28,29]. The increase in TH mRNA at a high cell den-
sity is correlated with higher levels of TH immunoreactive 
protein, increased enzymatic activity, and elevated dop-
amine content [4,8]. However, TH expression did not vary 
with increasing PC12 cell density (data not shown), possi-
bly due to the short-term culture conditions. Chromaffin Tyrosine hydroxylase expression in PC12 cells    381
cell differentiation was also not affected by increased cell 
density [30].
  Fourth, direct cell-cell contact may help enhance TH 
expression. Direct contact between bone marrow stromal 
cells and the host brain tissue is important for differ-
entiation [1]. Direct chromaffin cell contact may stimulate 
differentiation of neuronal progenitor cells [30]. The direct 
interaction of MSCs with neurons promoted long-last sur-
vival [31].
  In summary, co-culture of MSCs with PC12 cells in-
creases TH expression in the cultures. In vivo, MSCs from 
bone marrow markedly increase the proliferation of hippo-
campal-derived neural stem cells via secretion of cytokines 
[22]. Furthermore, MSCs transplantation into rats follow-
ing traumatic brain injury improved functional recovery 
[15]. However, only a small number of transplanted cells 
expressed neuronal antigens in that study, making func-
tional improvement in recipients unlikely. Therefore, the 
secretion of neurotrophic factors or direct cell-cell contact 
by MSCs may be more important than the resulting neural 
differentiation in transplant experiments. Our results imply 
a new role for MSCs in treating neurodegenerative dis-
eases such as PD. 
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